RAUL
ORTIZ DE LEJARAZU LEONARDO
Investigador en el periodo 1983-2019
Hospital Universitario de Valladolid
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (170)
2024
-
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
Scientific Reports, Vol. 14, Núm. 1
2023
-
Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people
Frontiers in Immunology, Vol. 14
-
Group 1 and group 2 hemagglutinin stalk antibody response according to age
Frontiers in Immunology, Vol. 14
-
Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults
Emerging Infectious Diseases, Vol. 29, Núm. 3, pp. 656-658
2022
-
Coinfections of influenza and other respiratory viruses are associated to children
Anales de Pediatria, Vol. 96, Núm. 4, pp. 334-341
2021
-
Do Vaccines Need a Gender Perspective? Influenza Says Yes!
Frontiers in Immunology, Vol. 12
-
Global influenza surveillance in times of COVID-19: Robbing Peter to pay Paul?
Revista Clinica Espanola
-
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
Frontiers in Microbiology, Vol. 12
-
Social distancing, lockdown and thewide use of mask; a magic solution or a double-edged sword for respiratory viruses epidemiology?
Vaccines, Vol. 9, Núm. 6
-
Vigilancia de la gripe y otros virus respiratorios durante la pandemia de Covid-19, un enfoque One Health: la asignatura pendiente (2ª parte)
Profesión veterinaria, Vol. 24, Núm. 96, pp. 59-70
2020
-
Adjuvanted influenza vaccines elicits higher antibody responses against the A(H3N2) subtype than non-adjuvanted vaccines
Vaccines, Vol. 8, Núm. 4, pp. 1-11
-
Effect of antiviral treatment in older patients hospitalized with confirmed influenza
Antiviral Research, Vol. 178
-
From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain
PLoS ONE, Vol. 15, Núm. 5
-
High-dose trivalent influenza vaccine. Efficacy and effectiveness
Revista Espanola de Quimioterapia, Vol. 33, Núm. 4, pp. 226-239
-
The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus
Vaccine, Vol. 38, Núm. 38, pp. 6047-6056
2019
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
Comparative study of the prevalence of the human papilloma virus in Spanish and foreign women participating in a population screening programme in Castilla y León
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 5, pp. 314-318
-
Diagnostic challenges in influenza
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, pp. 47-55
-
Epidemiological surveillance and wild-type MIC distribution of Legionella pneumophila in north-western Spain. 2003–2016
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 8, pp. 514-520
-
Heterotypic neuraminidase antibodies against different a(H1N1) strains are elicited after seasonal influenza vaccination
Vaccines, Vol. 7, Núm. 1